Representativity of TMA studies.
暂无分享,去创建一个
[1] Matthew Sydes,et al. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. , 2008, The Lancet. Oncology.
[2] R. Simon,et al. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer , 1998 .
[3] I. Jacobs,et al. Genetic intra‐tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours , 2007, The Journal of pathology.
[4] G. Sauter,et al. Distinct Subcellular Expression Patterns of Neutral Endopeptidase (CD10) in Prostate Cancer Predict Diverging Clinical Courses in Surgically Treated Patients , 2008, Clinical Cancer Research.
[5] M. J. van de Vijver,et al. Association of C‐MYC amplification with progression from the in situ to the invasive stage in C‐MYC‐amplified breast carcinomas , 2003, The Journal of pathology.
[6] J. Shah,et al. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays. , 2002, The American journal of pathology.
[7] G. Sauter,et al. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study. , 2009, Urology.
[8] M. Salto‐Tellez,et al. Reliability of Tissue Microarrays in Detecting Protein Expression and Gene Amplification in Breast Cancer , 2003, Modern Pathology.
[9] D. Rimm,et al. Validation of Tissue Microarray Technology in Breast Carcinoma , 2000, Laboratory Investigation.
[10] Lydia Sánchez,et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. , 2003, Blood.
[11] G. Sauter,et al. Pussycats and baby tigers: non‐invasive (pTa) and minimally invasive (pT1) bladder carcinomas are not the same! , 1998, The Journal of pathology.
[12] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[13] G. Sauter,et al. Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis , 2009, The Prostate.
[14] H. Moch,et al. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. , 2001, Journal of the National Cancer Institute.
[15] C. Cordon-Cardo,et al. High Ki‐67 proliferative index predicts disease specific survival in patients with high‐risk soft tissue sarcomas , 2001, Cancer.
[16] K. Pienta,et al. Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis , 2002, The American journal of surgical pathology.
[17] G. Sauter,et al. Tissue microarrays for comparing molecular features with proliferation activity in breast cancer , 2006, International journal of cancer.
[18] H. Moch,et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.
[19] C. Cordon-Cardo,et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. , 2001, The American journal of pathology.
[20] L. Bubendorf,et al. Expression patterns of potential therapeutic targets in prostate cancer , 2005, International journal of cancer.
[21] S. Pileri,et al. High‐throughput tissue microarray analysis of G1‐cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1 , 2003, The Journal of pathology.
[22] Holger Moch,et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade , 2001, The Journal of pathology.
[23] Y. Chen,et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. , 2000, Journal of the National Cancer Institute.
[24] Gieri Cathomas,et al. Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.
[25] H. Morreau,et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. , 2003, The American journal of pathology.
[26] Mårten Fernö,et al. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. , 2002, Archives of pathology & laboratory medicine.
[27] C. Pilarsky,et al. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics , 2008, British Journal of Cancer.
[28] A Semjonow,et al. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. , 2001, Cancer research.
[29] L. Hood,et al. WDR19 Expression is Increased in Prostate Cancer Compared with Normal Cells, but Low-Intensity Expression in Cancers is Associated with Shorter Time to Biochemical Failures and Local Recurrence , 2008, Clinical Cancer Research.
[30] A. Haese*,et al. Clinical significance of p53 alterations in surgically treated prostate cancers , 2008, Modern Pathology.
[31] A. Haese*,et al. Clinical Significance of Epidermal Growth Factor Receptor Protein Overexpression and Gene Copy Number Gains in Prostate Cancer , 2007, Clinical Cancer Research.
[32] E. Cho,et al. Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study , 2008, Journal of Korean medical science.
[33] Mef Nilbert,et al. Tissue Microarray Technique in Soft Tissue Sarcoma: Immunohistochemical Ki-67 Expression in Malignant Fibrous Histiocytoma , 2001, Applied immunohistochemistry & molecular morphology : AIMM.
[34] J. Teruya-Feldstein,et al. Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. , 2002, Human pathology.
[35] H. Moch,et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.